Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma.
Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma.
复制标题
DOI:
10.1038/s41598-021-96471-9
复制
发表时间:
2021-09-07
影响因子:
4.6
通讯作者:
Wendell SG
中科院分区:
文献类型:
--
作者:
Manni ML;Heinrich VA;Buchan GJ;O'Brien JP;Uvalle C;Cechova V;Koudelka A;Ukani D;Rawas-Qalaji M;Oury TD;Hart R;Ellgass M;Mullett SJ;Fajt ML;Wenzel SE;Holguin F;Freeman BA;Wendell SG
Bile acid profiles are altered in obese individuals with asthma. Thus, we sought to better understand how obesity-related systemic changes contribute to lung pathophysiology. We also test the therapeutic potential of nitro-oleic acid (NO2-OA), a regulator of metabolic and inflammatory signaling pathways, to mitigate allergen and obesity-induced lung function decline in a murine model of asthma. Bile acids were measured in the plasma of healthy subjects and individuals with asthma and serum and lung tissue of mice with and without allergic airway disease (AAD). Lung function, indices of inflammation and hepatic bile acid enzyme expression were measured in obese mice with house dust mite-induced AAD treated with vehicle or NO2-OA. Serum levels of glycocholic acid and glycoursodeoxycholic acid clinically correlate with body mass index and airway hyperreactivity whereas murine levels of β-muricholic acid and tauro-β-muricholic acid were significantly increased and positively correlated with impaired lung function in obese mice with AAD. NO2-OA reduced murine bile acid levels by modulating hepatic expression of bile acid synthesis enzymes, with a concomitant reduction in small airway resistance and tissue elastance. Bile acids correlate to body mass index and lung function decline and the signaling actions of nitroalkenes can limit AAD by modulating bile acid metabolism, revealing a potential pharmacologic approach to improving the current standard of care.
登录
查看更多内容
影响因子:
8
作者:
通讯作者:
--
影响因子:
14.2
作者:
Crestani, Elena;Harb, Hani;Chatila, Talal A.
通讯作者:
Chatila, Talal A.
DOI:
10.4049/jimmunol.1501531
发表时间:
2016-02-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Manni ML;Mandalapu S;McHugh KJ;Elloso MM;Dudas PL;Alcorn JF
通讯作者:
Alcorn JF
DOI:
10.1016/j.jaci.2011.03.036
发表时间:
2011-06
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Holguin F;Bleecker ER;Busse WW;Calhoun WJ;Castro M;Erzurum SC;Fitzpatrick AM;Gaston B;Israel E;Jarjour NN;Moore WC;Peters SP;Yonas M;Teague WG;Wenzel SE
通讯作者:
Wenzel SE
DOI:
10.1016/j.jaci.2011.02.042
发表时间:
2011-08
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Moore WC;Evans MD;Bleecker ER;Busse WW;Calhoun WJ;Castro M;Chung KF;Erzurum SC;Curran-Everett D;Dweik RA;Gaston B;Hew M;Israel E;Mayse ML;Pascual RM;Peters SP;Silveira L;Wenzel SE;Jarjour NN;National Heart, Lung, and Blood Institute's Severe Asthma Research Group
通讯作者:
National Heart, Lung, and Blood Institute's Severe Asthma Research Group